Evaluation of follicular T-helper cells in primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma and dermatitis

Journal of Cutaneous Pathology

Volumn 40, Issue 12, 2013, Pages 1006-1013

  Ally, Mina S ^a   Prasad Hunasehally, Ranganna Y ^b   Rodriguez Justo, Manuel ^c   Martin, Blanca ^a   Verdolini, Roberto ^d   Attard, Natalie ^a   Child, Fiona ^a   Attygalle, Ayoma ^e   Whittaker, Sean ^a   Morris, Stephen ^f   Robson, Alistair ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b PRINCESS OF WALES HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

cutaneous lymphoma; follicular T helper cell; PD 1; pseudolymphoma; small medium pleomorphic T cell lymphoma

Indexed keywords

CXCL13 CHEMOKINE; CXCL13 PROTEIN, HUMAN; ICOS PROTEIN, HUMAN; INDUCIBLE T CELL COSTIMULATOR; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; DERMATITIS; FEMALE; FOLLICULAR T-HELPER CELL; GENE EXPRESSION REGULATION; HELPER CELL; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PD-1; PSEUDOLYMPHOMA; RETROSPECTIVE STUDY; SKIN LYMPHOMA; SKIN TUMOR; SMALL/MEDIUM PLEOMORPHIC T-CELL LYMPHOMA;

CUTANEOUS LYMPHOMA; FOLLICULAR T-HELPER CELL; PD-1; PSEUDOLYMPHOMA; SMALL/MEDIUM PLEOMORPHIC T-CELL LYMPHOMA;

ADULT; AGED; CHEMOKINE CXCL13; DERMATITIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGRAMMED CELL DEATH 1 RECEPTOR; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84888639646     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12234     Document Type: Article

References (28)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768.
2. Khamaysi Z, Ben-Arieh Y, Epelbaum R, et al. Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma. Am J Dermatopathol 2006; 28: 434.
3. Lu D, Patel KA, Duvic M, et al. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol 2002; 29: 465.
4. Kempf W, Kazakov DV, Cozzio A, et al. Primary cutaneous CD8+ small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification. Am J Dermatopathol 2012; 35 (2): 159-66.
5. Rodriguez-Pinilla SM, Roncador G, Rodriguez-Peralto JL, et al. Primary cutaneous CD4 small/medium-sized pleomorphic T cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009; 33: 81.
6. Radkay L,. PD1 and CXCL13 staining in benign cutaneous lymphoid infiltrates. J Cutan Pathol 2012; 39: 165 (abstract).
7. Cetinözman F, Jansen PM, Willemze R,. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-Cell lymphoma, cutaneous pseudo-T-Cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol 2012; 36: 109.
8. Marafioti T, Paterson JC, Ballabio E, et al. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica 2010; 95: 432.
9. Baseggio L, Traverse-Glehen A, Berger F, et al. CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma. Mod Pathol 2011; 24: 1993.
10. Rijlaarsdam JU, Willemze R,. Cutanoues pseudolymphomas: classification and differential diagnosis. Semin Dermatol 1994; 13: 187.
11. Wawrzycki B, Chodorowska G, Pietrzak A, et al. Therapeutic hotline: primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide. Dermatol Ther 2010; 6: 676.
12. Messeguer F, Gimeno E, Agusti-Mejias A, et al. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-Cell lymphoma: report of a case with spontaneous resolution. Actas Dermosifiliogr 2011; 102: 636.
13. Baum CL, Link BK, Neppalli VT, et al. Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A series of 10 adult and pediatric patients and review of the literature. J Am Acad Dermatol 2011; 65: 739.
14. Beljaards R, Meijer C, van der Putte S, et al. Primary cutaneous T-cell lymphoma: clinicopathologic features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. J Pathol 1994; 172: 53.
15. Friedmann D, Wechsler J, Delfau MH, et al. Primary cutaneous pleomorphic small T-cell lymphoma: a review of 11 cases. Arch Dermatol 1995; 131: 1009.
16. Bekkenk MW, Vermeer MH, Jansen PM, et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood 2003; 102: 2213.
17. Beltraminelli H, Leinweber B, Kerl H, et al. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol 2009; 4: 317.
18. Grogg KL, Jung S, Erickson LA, et al. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol 2008; 21: 708.
19. Garcia-Herrera A, Colomo L, Camõs M, et al. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. J Clin Oncol 2008; 20: 3364.
20. Vezzoli P, Fiorani R, Girgenti V, et al. Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature. Dermatology 2011; 3: 225.
21. von den Driesch P, Coors EA,. Localized cutaneous small to medium-sized pleomorphic T-cell lymphoma: a report of 3 cases stable for years. J Am Acad Dermatol 2002; 46: 531.
22. Fierro MT, Ponti R, Titli S, et al. TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. J Invest Dermatol 2010; 130: 2312.
23. Brady SP, Magro CM, Diaz-Cano SJ, et al. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE. Hum Pathol 1999; 2: 130.
24. Cetinözman F, Jansen PM, Vermeer MH, Willemze R,. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides. Arch Dermatol 2012; 148: 1379.
25. Battistella M, Beylot-Barry M, Bachelez H, et al. Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases. Arch Dermatol 2012; 148: 832.
26. Cardoso J, Benton E, Naresh K, et al. Angioimmunoblastic T-cell lymphoma; dermatopathological features in a series of 40 cases. Modern Pathol Suppl 2011; 24: 114A No. 471 (abstract).
27. Attygalle AD, Diss TC, Munson P, et al. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2004; 28: 54.
28. Ortonne N, Kebir F, Chaby G, et al. Cutaneous Follicular Helper T-cell Lymphomas: a series of 6 cases highlighting new clinical-pathological aspects. P-17, EORTC CLTF Vienna September 7th-9th 2012.